Roberto Patarca-Montero

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Roberto Patarca)

Roberto Patarca-Montero, MD, PhD. Former Assistant Professor at University of Miami School of Medicine. Former editor of the Journal of Chronic Fatigue Syndrome. Researcher for AIDS and chronic fatigue syndrome.

Books[edit | edit source]

  • 2000, Concise Encyclopedia of Chronic Fatigue Syndrome[1]
  • 2001, Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era: What Does the Research Say?[2]
  • 2001, Phytotherapy of Chronic Fatigue Syndrome: Evidence-Based and Potentially Useful Botanicals in the Treatment of CFS[3]
  • 2002, Chronic Fatigue Syndrome and the Body's Immune Defense System: What Does the Research Say?[4]
  • 2002, The Concise Encyclopedia of Fibromyalgia and Myofascial Pain[5]
  • 2003, Chronic Fatigue Syndrome, Genes, and Infection: The ETA-1/OP Paradigm — What Does the Literature Say?[6]
  • 2004, Medical Etiology, Assessment, and Treatment of Chronic Fatigue and Malaise: Clinical Differentiation and Intervention; What Does the Research Say?[7]
  • 2004, Handbook of Cancer-Related Fatigue: What Does the Research Say?[8]

Notable studies[edit | edit source]

  • 1994, Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression[9] - (Abstract)
  • 1995, Dysregulated Expression of Soluble Immune Mediator Receptors in a Subset of Patients with Chronic Fatigue Syndrome: Cross-Sectional Categorization of Patients by Immune Status[10] - (Abstract)
  • 1998, Interleukin-6 and Disease: Two Case Reports that Point to the Usefulness of Measuring Cytokine Levels in Clinical Settings[11]
  • 2000, Comparative Analysis of Lymphocytes in Lymph Nodes and Peripheral Blood of Patients with Chronic Fatigue Syndrome[12]
  • 2000, Clinical and Immunologic Effects of Autologous Lymph Node Cell Transplant in Chronic Fatigue Syndrome[13] - (Abstract)
  • 2000, Immunotherapy of Chronic Fatigue Syndrome: Therapeutic Interventions Aimed at Modulating the Th1/Th2 Cytokine Expression Balance[14] - Abstract)
  • 2001, Cytokine and Other Immunologic Markers in Chronic Fatigue Syndrome and Their Relation to Neuropsychological Factors[15] - (Abstract)
  • 2002, Effects of Benzalkonium Salts on G-protein-Mediated Processes and Surface Membranes: Relevance to Microbial- and Chemical-Induced Diseases[16]
  • 2002, Cytolytic Cells and Their Function[17]
  • 2002, The Paul-Bunnell Heterophile Antibody Determinant in Epstein-Barr Virus-Associated Disease[18]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ Patarca-Montero, Roberto (2000). Concise Encyclopedia of Chronic Fatigue Syndrome. ISBN 0789009226.
  2. ↑ Patarca-Montero, Roberto (2001). Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era: What Does the Research Say?. ISBN 0789012537.
  3. ↑ Roberto Patarca-Montero (2001). Phytotherapy of Chronic Fatigue Syndrome: Evidence-Based and Potentially Useful Botanicals in the Treatment of CFS. ISBN 0789009099.
  4. ↑ Roberto Patarca-Montero (2002). Chronic Fatigue Syndrome and the Body's Immune Defense System: What Does the Research Say?. ISBN 0789015293.
  5. ↑ Patarca-Montero, Roberto (2002). The Concise Encyclopedia of Fibromyalgia and Myofascial Pain. ISBN 0789015277.
  6. ↑ Patarca-Montero, Roberto (2003). Chronic Fatigue Syndrome, Genes, and Infection: The ETA-1/OP Paradigm—What Does the Literature Say?. ISBN 0789017938.
  7. ↑ Patarca-Montero, Roberto (2004). Medical Etiology, Assessment, and Treatment of Chronic Fatigue and Malaise: Clinical Differentiation and Intervention; What Does the Research Say? (1st ed.). Binghamton, NY: Taylor Francis. ISBN 0789021951.
  8. ↑ Patarca-Montero, Roberto (2004). Handbook of Cancer-Related Fatigue: What Does the Research Say?. ISBN 0789021684.
  9. ↑ Patarca, Roberto; Klimas, Nancy; Lugtendorf, S; Antoni, Michael H.; Fletcher, Mary Ann (1994). "Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression". Clinical Infectious Diseases. 18: S147-53. PMID 8148443.
  10. ↑ Patarca, Roberto; Klimas, Nancy; Garcia, Maria N.; Walters, Michael J.; Dombroski, Derek; Pons, Hector (1995). "Dysregulated Expression of Soluble Immune Mediator Receptors in a Subset of Patients with Chronic Fatigue Syndrome: Cross-Sectional Categorization of Patients by Immune Status". Journal of Chronic Fatigue Syndrome. 1 (1): 81–96. doi:10.1300/J092v01n01_06.
  11. ↑ Patarca, Roberto; Fletcher, Mary Ann (1998). "Interleukin-6 and Disease: Two Case Reports that Point to the Usefulness of Measuring Cytokine Levels in Clinical Settings". Journal of Chronic Fatigue Syndrome. 4 (1): 53–69.
  12. ↑ Fletcher, Mary Ann; Maher, Kevin; Patarca-Montero, Roberto; Klimas, Nancy (2000). "Comparative Analysis of Lymphocytes in Lymph Nodes and Peripheral Blood of Patients with Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 7 (3): 65–75. doi:10.1300/J092v07n03_06.
  13. ↑ Klimas, Nancy; Patarca-Montero, Roberto; Maher, Kevin; Fletcher, Mary Ann (2000). "Immunotherapy of Chronic Fatigue Syndrome: Therapeutic Interventions Aimed at Modulating the Th1/Th2 Cytokine Expression Balance". Journal of Chronic Fatigue Syndrome. 8 (1): 39-55. doi:10.1300/J092v08n01_03.
  14. ↑ Patarca-Montero, Roberto; Klimas, Nancy G.; Fletcher, Mary Ann (2000). "Immunotherapy of Chronic Fatigue Syndrome: Therapeutic Interventions Aimed at Modulating the Th1/Th2 Cytokine Expression Balance". Journal of Chronic Fatigue Syndrome. 8 (1): 3–37. doi:10.1300/J092v08n01_02.
  15. ↑ Patarca-Montero, Roberto; Antoni, Michael; Fletcher, Mary Ann; Klimas, Nancy G. (March 2001). "Cytokine and Other Immunologic Markers in Chronic Fatigue Syndrome and Their Relation to Neuropsychological Factors". Applied Neuropsychology. 8 (1): 51–64. doi:10.1207/S15324826AN0801_7. ISSN 0908-4282.
  16. ↑ Roberto Patarca-Montero & Mary Ann Fletcher. Effects of Benzalkonium Salts on G-protein-Mediated Processes and Surface Membranes: Relevance to Microbial- and Chemical-Induced Diseases. Journal of Chronic Fatigue Syndrome, Vol. 10, Iss. 2, pp. 87-168. http://dx.doi.org/10.1300/J092v10n03_07
  17. ↑ Roberto Patarca-Montero. (2002). Subjective Sleep Quality and Depressive Symptoms in Patients with the Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 10, Iss. 2, pp. 29-58. http://dx.doi.org/10.1300/J092v10n02_04
  18. ↑ Roberto Patarca-Montero & Mary Ann Fletcher. The Paul-Bunnell Heterophile Antibody Determinant in Epstein-Barr Virus-Associated Disease. Journal of Chronic Fatigue Syndrome, Vol. 10, Iss. 2, pp. 51-86. http://dx.doi.org/10.1300/J092v10n03_06
Retrieved from "https://me-pedia.org/w/index.php?title=Roberto_Patarca-Montero&oldid=241297"